CYP11A1 and neoplasm: Similar to the genetic deletion of Cyp11a1, application of the Cyp11a1 inhibitor aminoglutethimide significantly increased frequencies of M1 macrophages and degranulating T and NK cells (Fig. 6i–l, Supplementary Fig. 5b), recapitulating anti-tumor phenotypes.